Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer

Abstract

Mutational inactivation of the RB-related gene RBL2/p130 has been reported as a common and important prognostic factor in human lung cancer. To examine the role of the RB-related gene family in lung cancer we analysed the protein expression of the RB gene in cell lines obtained from 83 patients with small cell lung cancer (SCLC) and 114 patients with non-SCLC that included 21 novel lung tumor samples. While we detected five new SCLC with mutant RB expression (RB inactivation in 75/83; 90.4%), we did not detect any RB mutations in the new non-SCLC cell lines (RB inactivation in 13/114 non-SCLC and mesothelioma; 11.4%). In addition, we detected expression of a full-length RBL1/p107 and RBL2/p130 species in every sample tested (RBL1 or RBL2 inactivation in 0/69) and confirmed that both RB-related gene products retain functional binding activity to the E1A viral oncoprotein. Since expression of SV40 Large T antigen (Tag) has been reported in a subset of human lung tumors where it may inactivate RBL1 and RBL2, we also examined mesothelioma and non-mesothelioma lung tumors for Tag expression. Although we detected a faint 85 kDa protein species using specific anti-Tag antibodies, this signal migrated slightly faster than Tag extracted from Cos7 cells and did not exhibit binding activity to the RB or RBL1 proteins. Finally, we subjected 11 lung cancer cell lines to nucleotide sequencing and did not detect mutations within the C-terminal RBL2 exons 19–22 as recently reported. While the RB/p16 tumor suppressor pathway is targeted for mutations in 100% of lung cancers, mutational inactivation of the related RBL1 and RBL2 genes is a rare event.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Baldi A, Esposito V, De Luca A, Fu Y, Meoli I, Giordano GG, Caputi M, Baldi F and Giordano A. . 1997 Clin. Cancer Res. 3: 1691–1697.

  • Baldi A, Esposito V, De Luca A, Howard CM, Mazzarella G, Baldi F, Caputi M and Giordano A. . 1996 Clin. Cancer Res. 2: 1239–1245.

  • Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ and Garcea RL. . 1992 N. Engl. J. Med. 326: 988–993.

  • Brehm A and Kouzarides T. . 1999 Trends Biochem. Sci. 24: 142–145.

  • Butel JS and Lednicky JA. . 1999 J. Natl. Cancer Inst. 91: 119–134.

  • Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJ, Levine AS and Procopio A. . 1994 Oncogene 9: 1781–1790.

  • Carbone M, Rizzo P and Pass HI. . 1997 Oncogene 15: 1877–1888.

  • Carbone M, Rizzo P, Procopio A, Giuliano M, Pass HI, Gebhardt MC, Mangham C, Hansen M, Malkin DF, Bushart G, Pompetti F, Picci P, Levine AS, Bergsagel JD and Garcea RL. . 1996 Oncogene 13: 527–535.

  • Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH and Minna JD. . 1985 Cancer Res. 45: 2913–2923.

  • Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC and Nevins JR. . 1992 Proc. Natl. Acad. Sci. USA 89: 4549–4553.

  • Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee WC, Altomare DA, Nobori T, Olopade OI, Buckler AJ and Testa JR. . 1994 Cancer Res. 54: 5547–5551.

  • Christensen JB and Imperiale MJ. . 1995 J. Virol. 69: 3945–3948.

  • Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B and Giordano A. . 1994 Cancer Res. 54: 5556–5560.

  • Claudio PP, Howard CM, Fu Y, Cinti C, Califano L, Micheli P, Mercer EW, Caputi M and Giordano A. . 2000a Cancer Res. 60: 8–12.

  • Claudio PP, Howard CM, Pacilio C, Cinti C, Romano G, Minimo C, Maraldi NM, Minna JD, Gelbert L, Leoncini L, Tosi GM, Hicheli P, Caputi M, Giordano GG and Giordano A. . 2000b Cancer Res. 60: 372–382.

  • Cobrinik D, Whyte P, Peeper DS, Jacks T and Weinberg RA. . 1993 Genes Dev. 7: 2392–2404.

  • Corbeil HB, Whyte P and Branton PE. . 1995 Oncogene 11: 909–920.

  • De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, Caputi M, Pass HI, Giordano GG, Baldi F, Carbone M and Giordano A. . 1997 Nat. Med. 3: 913–916.

  • Dyson N. . 1998 Genes Dev. 12: 2245–2262.

  • Dyson N, Dembski M, Fattaey A, Ngwu C, Ewen M and Helin K. . 1993 J. Virol 67: 7641–7647.

  • Eberhard D and Busslinger M. . 1999 Cancer Res. 59: 1716s–1724s; discussion 1724s–1725s.

  • Ewen ME, Xing YG, Lawrence JB and Livingston DM. . 1991 Cell 66: 1155–1164.

  • Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD and Kaye FJ. . 1988 Science 241: 353–357.

  • Helin K, Holm K, Niebuhr A, Eiberg H, Tommerup N, Hougaard S, Poulsen HS, Spang-Thomsen M and Norgaard P. . 1997 Proc. Natl. Acad. Sci. USA 94: 6933–6938.

  • Howard CM, Claudio PP, Gallia G, Gordon J, Giordano GG, Hauck WH, Khalili K and Giordano A. . 1998 J. Natl. Cancer Inst. 90: 123–456.

  • Kaelin Jr W, Pallas DC, DeCaprio JA, Kaye FJ and Livingston DM. . 1991 Cell 64: 521–532.

  • Kaye FJ, Kratzke RA, Gerster JL and Horowitz JM. . 1990 Proc. Natl. Acad. Sci. USA 87: 6922–6926.

  • Kelley MJ, Otterson GA, Kaye FJ, Popescu NC, Johnson BE and Dipaolo JA. . 1995 Int. J. Cancer 63: 226–230.

  • Kohno T and Yokota J. . 1999 Carcinogenesis 20: 1403–1410.

  • Kratzke RA, Otterson GA, Hogg A, Coxon AB, Geradts J, Cowell JK and Kaye FJ. . 1994 Oncogene 9: 1321–1326.

  • Kratzke RA, Otterson GA, Lincoln CE, Ewing S, Oie H, Geradts J and Kaye FJ. . 1995 J. Natl. Cancer Inst. 87: 1870–1875.

  • Le Couter JE, Kablar B, Whyte PFM, Ying C and Rudnicki A. . 1998 Development 125: 4669–4679.

  • Lee JO, Russo AA and Pavletich NP. . 1998 Nature 391: 859–865.

  • Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E and Jacks T. . 1996 Genes Dev. 10: 1621–1632.

  • Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N and Helin K. . 1993 Mol. Cell Biol. 13: 7813–7825.

  • Lipinski MM and Jacks T. . 1999 Oncogene 18: 7873–7882.

  • Lohmann DR. . 1999 Hum. Mutat. 14: 283–288.

  • Mulligan G and Jacks T. . 1998 Trends Genet 14: 223–229.

  • Nevins JR. . 1998 Cell Growth Differ 9: 585–593.

  • Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB and Herman JG. . 1999 Proc. Natl. Acad. Sci. USA 96: 12754–12759.

  • Otterson GA, Kratzke RA, Coxon A, Kim YW and Kaye FJ. . 1994 Oncogene 9: 3375–3378.

  • Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA. . 1998 Cell 92: 713–723.

  • Scheffner M, Munger K, Byrne JC and Howley PM. . 1991 Proc. Natl. Acad. Sci. USA 88: 5523–5527.

  • Shimizu E, Coxon A, Otterson GA, Steinberg SM, Kratzke RA, Kim YW, Fedorko J, Oie H, Johnson BE, Mulshine JL, Minna JD, Gazdar AF and Kaye FJ. . 1994 Oncogene 9: 2441–2448.

  • Smith EJ, Leone G, DeGregori J, Jakoi L and Nevins JR. . 1996 Mol. Cell Biol. 16: 6965–6976.

  • Starostik P, Chow KN and Dean DC. . 1996 Mol. Cell Biol. 16: 3606–3614.

  • Vairo G, Livingston DM and Ginsberg D. . 1995 Genes Dev. 9: 869–881.

  • Wang JY, Knudsen ES and Welch PJ. . 1994 Adv. Cancer Res. 64: 25–85.

  • Wang S, Ghosh RN and Chellappan SP. . 1998 Mol. Cell Biol. 18: 7487–7498.

  • Weinberg RA. . 1995 Cell 81: 323–330.

  • Yee AS, Shih HN and Tevosian SG. . 1998 Front. Biosci. 3: D532–D547.

  • Yokota J, Akiyama T, Fung YK, Benedict WF, Namba Y, Hanaoka M, Wada M, Terasaki T, Shimosato Y, Sugimura T and Terada M. . 1988 Oncogene 3: 471–475.

  • Zalvide J and DeCaprio JA. . 1995 Mol. Cell Biol. 15: 5800–5810.

  • Zalvide J, Stubdal H and DeCaprio JA. . 1998 Mol. Cell Biol. 18: 1408–1415.

  • Zhang Y, Xiong Y and Yarbrough WG. . 1998 Cell 92: 725–734.

  • Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N and Harlow E. . 1993 Genes Dev. 7: 1111–1125.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Modi, S., Kubo, A., Oie, H. et al. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer. Oncogene 19, 4632–4639 (2000). https://doi.org/10.1038/sj.onc.1203815

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203815

Keywords

This article is cited by

Search

Quick links